{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T11:30:31Z","timestamp":1664191831099},"reference-count":37,"publisher":"Japanese Society of Internal Medicine","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.8617-16","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T22:10:20Z","timestamp":1507673420000},"page":"3341-3346","source":"Crossref","is-referenced-by-count":1,"title":["A Rare Monocytic Crisis of Chronic Myelogenous Leukemia Presenting with Unusual Extramedullary Manifestations and an Atypical (14;22)(q24;q11.2) Translocation in the Bone Marrow"],"prefix":"10.2169","volume":"56","author":[{"given":"Morihiro","family":"Inoue","sequence":"first","affiliation":[{"name":"Depatment of Hematology, Eiju General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Hagihara","sequence":"additional","affiliation":[{"name":"Depatment of Hematology, Eiju General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Uchida","sequence":"additional","affiliation":[{"name":"Depatment of Hematology, Eiju General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Hua","sequence":"additional","affiliation":[{"name":"Depatment of Hematology, Eiju General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Opthalmology, Eiju General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Tajima","sequence":"additional","affiliation":[{"name":"Department of Pathology, Eiju General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunori","family":"Ota","sequence":"additional","affiliation":[{"name":"Department of Pathology, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","first-page":"146","volume":"75","author":"D Inverardi","year":"1990","unstructured":"1. Inverardi D, Lazzarino M, Morra E, et al. Extramedullary disease in Ph&apos;-positive chronic myelogenous leukemia: frequency, clinical features and prognostic significance. Haematologica 75: 146-148, 1990.","journal-title":"Haematologica","ISSN":"http:\/\/id.crossref.org\/issn\/0390-6078","issn-type":"print"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Terjanian T, Kantarjian H, Keating M, Talpaz M, McCredie K, Freireich EJ. Clinical and prognostic features of patients with Philadelphia chromosome-positive chronic myelogenous leukemia and extramedullary disease. Cancer 59: 297-300, 1987.","DOI":"10.1002\/1097-0142(19870115)59:2<297::AID-CNCR2820590221>3.0.CO;2-B"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Specchia G, Palumbo G, Pastore D, Mininni D, Mestice A, Liso V. Extramedullary blast crisis in chronic myeloid leukemia. Leukemia research 20: 905-908, 1996.","DOI":"10.1016\/S0145-2126(96)00054-9"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Soni A, Paluri R, Deal T, Peker D. Extramedullary involvement by chronic myelogeneous leukemia in five patients with unusual clinicopathologic features: a review of the effectiveness of tyrosine kinase inhibitors. J Clin Med Res 8: 480-485.","DOI":"10.14740\/jocmr2566w"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Aleem A, Siddiqui N. Chronic myeloid leukemia presenting with extramedullary disease as massive ascites responding to imatinib mesylate. Leuk Lymphoma 46: 1097-1099, 2005.","DOI":"10.1080\/10428190500096781"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Au WY, Chan AC, Lie AK, So JC, Liang R, Kwong YL. Isolated extramedullary relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplant 22: 99-102, 1998.","DOI":"10.1038\/sj.bmt.1701294"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Smaradottir A, Kapur D, Bilgrami S. Unusual extramedullary relapse of CML. Ann Oncol 15: 1296-1297, 2004.","DOI":"10.1093\/annonc\/mdh321"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Tsukamoto S, Ota S, Ohwada C, et al. Extramedullary blast crisis of chronic myelogenous leukemia as an initial presentation. Leuk Res Rep 2: 67-69, 2013.","DOI":"10.1016\/j.lrr.2013.07.002"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Levy RA, Mardones MA, Burch MM, Krause JR. Myeloid sarcoma as the presenting symptom of chronic myelogenous leukemia blast crisis. Proc (Bayl Univ Med Cent) 27: 246-249, 2014.","DOI":"10.1080\/08998280.2014.11929127"},{"key":"10","unstructured":"10. Aftimos P, Nasr F. Isolated CNS lymphoid blast crisis in a patient with imatinib-resistant chronic myelogenous leukemia: case report and review of the literature. Leukemia Res 33: e178-e180, 2009."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Pavlu J, Czepulkowski B, Kaczmarski R, Jan-Mohamed R. Early blastic transformation with CNS infiltration in a patient with chronic myeloid leukaemia treated with imatinib. Lancet Oncol 6: 128, 2005.","DOI":"10.1016\/S1470-2045(05)01744-4"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Fuchs M, Reinhofer M, Ragoschke-Schumm A, et al. Isolated central nervous system relapse of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation. BMC Blood Disord 12: 9, 2012.","DOI":"10.1186\/1471-2326-12-9"},{"key":"13","unstructured":"13. Lindhorst SM, Lopez RD, Sanders RD. An unusual presentation of chronic myelogenous leukemia: a review of isolated central nervous system relapse. J Natl Compr Canc Netw 11: 745-749; quiz 750, 2013."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Cho SF, Liu TC, Lu CY, Chang CS. Epidural leukemic involvement and intracranial hemorrhage as initial manifestations in a newly diagnosed chronic myeloid leukemia patient. Ann Hematol 90: 607-609, 2011.","DOI":"10.1007\/s00277-010-1061-7"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Prasad BC, Chandra VV, Varaprasad G. Dural metastases in chronic myeloid leukemia presenting as subdural hematoma. Turk Neurosurg 22: 777-778, 2012.","DOI":"10.5137\/1019-5149.JTN.4050-10.2"},{"key":"16","unstructured":"16. Jain A, Gupta N. Isolated CNS blast crises in chronic myeloid leukaemia presenting as hypertrophic pachymeningitis and bilateral optic neuritis: a case report. J Clin Diagn Res 10: OE01-05, 2016."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Schocket LS, Massaro-Giordano M, Volpe NJ, Galetta SL. Bilateral optic nerve infiltration in central nervous system leukemia. Am J Ophthalmol 135: 94-96, 2003.","DOI":"10.1016\/S0002-9394(02)01847-0"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Costagliola C, Rinaldi M, Cotticelli L, Sbordone S, Nastri G. Isolated optic nerve involvement in chronic myeloid leukemia. Leuk Res 16: 411-413, 1992.","DOI":"10.1016\/0145-2126(92)90144-V"},{"key":"19","unstructured":"19. Gulati R, Alkhatib Y, Donthireddy V, Felicella MM, Menon MP, Inamdar KV. Isolated ocular manifestation of relapsed chronic myelogenous leukemia presenting as myeloid blast crisis in a patient on imatinib therapy: a case report and review of the literature. Case Rep Pathol 2015: 380451, 2015."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kincaid MC, Green WR. Ocular and orbital involvement in leukemia. Surv Ophthalmol 27: 211-232, 1983.","DOI":"10.1016\/0039-6257(83)90123-6"},{"key":"21","unstructured":"21. Kaikov Y. Optic nerve head infiltration in acute leukemia in children: an indication for emergency optic nerve radiation therapy. Med Pediatr Oncol 26: 101-104, 1996."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Satake A, Okada M, Asada T, et al. Dasatinib is effective against optic nerve infiltration of Philadelphia chromosome-positive acute lymphoblastic leukemia. Leuk Lymphoma 51: 1920-1922, 2010.","DOI":"10.3109\/10428194.2010.509453"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Sakakura M, Ohishi K, Nomura K, et al. Case of chronic-phase chronic myelogenous leukemia with an abdominal hematopoietic tumor of leukemic clone origin. Am J Hematol 77: 167-170, 2004.","DOI":"10.1002\/ajh.20165"},{"key":"24","unstructured":"24. Kobayashi Y, Tanaka T, Kawata E, Akaogi T. Chronic myelogenous leukemia in the chronic phase with lymph node swelling which represented extramedullary involvement composed of cells at different stages of maturation. Rinsho Byori (Jpn J Clin Pathol) 59: 360-363, 2011."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kantarjian HM, Kurzrock R, Talpaz M. Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia. Hematol Oncol Clin North Am 4: 389-404, 1990.","DOI":"10.1016\/S0889-8588(18)30494-5"},{"key":"26","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1182\/blood.V66.6.1326.1326","volume":"66","author":"HM Kantarjian","year":"1985","unstructured":"26. Kantarjian HM, Smith TL, McCredie KB, et al. Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival. Blood 66: 1326-1335, 1985.","journal-title":"Blood","ISSN":"http:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Asinari MB, Zeballos M, Alicia S, Ricchi BN, Basquiera AL. A case of chronic myeloid leukemia with the m-bcr (p190) molecular rearrangement identified during treatment. Rev Bras Hematol Hemoter 37: 55-57.","DOI":"10.1016\/j.bjhh.2014.07.024"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Ohsaka A, Shiina S, Kobayashi M, Kudo H, Kawaguchi R. Philadelphia chromosome-positive chronic myeloid leukemia expressing p190(BCR-ABL). Intern Med 41: 1183-1187, 2002.","DOI":"10.2169\/internalmedicine.41.1183"},{"key":"29","first-page":"208","volume":"8","author":"JV Melo","year":"1994","unstructured":"29. Melo JV, Myint H, Galton DA, Goldman JM. P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia? Leukemia 8: 208-211, 1994.","journal-title":"Leukemia","ISSN":"http:\/\/id.crossref.org\/issn\/0887-6924","issn-type":"print"},{"key":"30","unstructured":"30. Wang Z, Zen W, Meng F, et al. Chronic myeloid leukemia with variation of translocation at (Ph) [ins (22;9) (q11;q21q34)]: a case report. Int J Clin Exp Pathol 8: 13707-13710, 2015."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Huret JL. Complex translocations, simple variant translocations and Ph-negative cases in chronic myelogenous leukaemia. Hum Genet 85: 565-568, 1990.","DOI":"10.1007\/BF00193575"},{"key":"32","unstructured":"32. La Starza R, Testoni N, Lafage-Pochitaloff M, et al. Complex variant Philadelphia translocations involving the short arm of chromosome 6 in chronic myeloid leukemia. Haematologica 87: 143-147, 2002."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Wang W, Cortes JE, Tang G, et al. Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy. Blood 127: 2742-2750, 2016.","DOI":"10.1182\/blood-2016-01-690230"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Tsunemine H, Arima H, Itoh K, et al. Monocytic crisis of chronic myeloid leukemia in the era of tyrosine kinase inhibitor. J Clin Exp Hematop 53: 227-233, 2013.","DOI":"10.3960\/jslrt.53.227"},{"key":"35","doi-asserted-by":"publisher","unstructured":"35. Porkka K, Koskenvesa P, Lundan T, et al. Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia. Blood 112: 1005-1012, 2008.","DOI":"10.1182\/blood-2008-02-140665"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Menzel H, von Bubnoff N, Hochhaus A, Haferlach C, Peschel C, Duyster J. Successful allogeneic stem cell transplantation in second chronic-phase CML induced by the tyrosine kinase inhibitor nilotinib (AMN107) after blast crisis under imatinib. Bone Marrow Transplant 40: 83-84, 2007.","DOI":"10.1038\/sj.bmt.1705683"},{"key":"37","unstructured":"37. Eissa H, Gooley TA, Sorror ML, et al. Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: relapse-free survival is determined by karyotype and comorbidities. Biol Blood Marrow Transplant 17: 908-915, 2011."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/24\/56_8617-16\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T08:40:14Z","timestamp":1603096814000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/24\/56_8617-16\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":37,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8617-16","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}